Imaging software developer Median Technologies has expanded its collaboration agreement with South Texas Accelerated Research Therapeutics (START).
START conducts the world's largest phase I medical oncology program, putting more than 600 patients per year in phase I trials, Median said. It has two centers in the U.S., two in Spain, one in China, and one in Taiwan.
Median Technologies has been START's sole provider of imaging services at its San Antonio site for the past two years. Under terms of the expanded agreement, START researchers at its Grand Rapids, MI, and Madrid sites will be able to use Median's Lesion Management Solutions (LMS) software application, according to the firm.
